(917) 310-3371
Long Island
Hicksville
232 W Old Country Rd, Hicksville, NY 11801
A Long Island location for opioid addiction treatment, medication follow-up, and insurance-supported recovery care.
View local MAT details Get directions
OASAS-certified treatment is a specific regulated treatment path. It is separate from routine office-based Suboxone or telemedicine MAT visits.
Coverage depends on your exact plan, clinician, location and service. Check participation and expected charges with the clinic and your insurer before booking.
Addiction care can include medical visits, counseling and continuing support. If your request requires an OASAS-certified program, check the exact provider and location in OASAS’s directory. This is a specific program entry. To start, ask for an assessment through the outpatient program and confirm whether that program or a focused medication visit best fits your needs. The listed program should not be treated as a certification claim for every Nao Medical location.
An outpatient program can combine a substance-use assessment with counseling, education and connections to recovery resources at an appropriate intensity. A focused medical visit may address a medication decision or continuation. These services can work together, but they need a clear plan for who handles medication, counseling, monitoring and referrals.
Describe the substances used, recent changes, withdrawal or overdose history, current medicines, mental-health symptoms and previous treatment. Discuss your goals and daily responsibilities. The assessment should clarify the recommended care intensity, the next appointment and whether another setting is safer. Ask what the proposed program actually includes and how often attendance is recommended.
A certification or program listing is not a personal determination that withdrawal can be managed safely there. Tell the clinician about past alcohol or benzodiazepine seizures, delirium, heavy use and new symptoms. Severe confusion, a seizure, unresponsiveness or trouble breathing require emergency care. Do not wait for a routine outpatient appointment or use a general outpatient description as a home-detox plan.
Bring the original order, referral, deadline and required evaluator or report details. A Part 822 outpatient listing does not establish that every assessment will meet a court, employer or DMV requirement. New York impaired-driving assessments have a separate approved-provider pathway. Confirm that the intended service and evaluator meet the written requirement before expecting a report to be accepted.
The official program directory marks Telehealth Services for this Mineola program. Ask which sessions can occur virtually, along with current admission availability, the actual counseling and medication schedule and your exact insurance plan. If you are transferring from rehabilitation or another prescriber, bring the discharge plan and last treatment dates. Confirm who will handle missed visits, prescription continuity and a need for more intensive care.
Outpatient addiction care means receiving treatment while living outside a residential program. It can include medical evaluation, medication management, behavioral treatment and recovery support. The actual intensity varies: a periodic medication visit is different from an intensive outpatient program. After detox or rehab, the goal is to connect the discharge plan to care that continues in daily life.
Ongoing care addresses more than the immediate withdrawal. Medication can treat specific disorders, behavioral care can address triggers and coping, and practical support can help with barriers to attending treatment. Recovery support does not replace urgent medical care or guarantee abstinence. The plan should be based on current needs and reviewed as circumstances change.
The assessment reviews substance use, medical and psychiatric stability, treatment history, overdose risk and available support. Some people can be treated safely in routine outpatient care; others need intensive outpatient, residential or inpatient treatment. Recent discharge is not proof that the same level of care remains suitable. Repeated relapse, unsafe symptoms or difficulty following the plan can prompt reassessment.
Bring medication names, the last administered dose or injection, remaining supply, discharge instructions and scheduled referrals. Clarify who currently owns the prescription and when the next dose is due. Identify gaps before medication or follow-up is missed.
Describe use since discharge, cravings, mood, sleep, home support and access barriers. The clinician considers whether routine appointments are enough or another setting is needed. Ask what the proposed program actually includes and how often treatment occurs; a broad outpatient label is not a schedule.
Discuss the treating prescribers, therapy, recovery support and other health needs. Agree on information sharing with your consent and clarify the role of each clinician. Ask about help with referral navigation, insurance or other barriers without assuming the clinic can directly provide every service.
Identify situations likely to trigger use and an action you can take before a crisis. Agree on how to obtain reassessment after a lapse and where to seek emergency help. If opioids are involved, review lower tolerance and naloxone after time without use. Keep care connected even if the original plan needs to change.
Arrange follow-up before discharge when possible. Bring treatment records and a complete medication list, including prescriptions for sleep, anxiety or pain. Tell the team about housing changes, court or employer requirements and support preferences. Ask what must be confirmed before transfer and what to do if the first appointment is later than the remaining medication supply.
Seek emergency care for overdose, severe withdrawal, chest symptoms, dangerous confusion or inability to stay safe. Following a period without opioids, a return to previous amounts can be especially dangerous. Do not abruptly stop a prescribed sedative or OUD medicine to qualify for a program. A referral should preserve appropriate treatment while the receiving service reassesses safety.
Follow-up reviews use, cravings, medication response, daily function, relationships and practical barriers. Testing may support care when appropriate, but should be interpreted with the history. If symptoms or use worsen, discuss a more intensive level of treatment. Completing a program is a transition point rather than a guarantee that medication or support should end.
Ask whether the service offers ongoing medication visits, individual or group therapy, intensive outpatient treatment or referrals. Confirm eligibility, frequency, fees and the first available appointment. Verify insurance requirements and medication coverage separately. Confirm whether the actual service is outpatient care, a referral or a residential program.
Bring the exact court, probation, DMV or employer instruction and deadline. An ordinary outpatient treatment visit, CASAC counseling, an OASAS-certified program, an impaired-driver assessment and a DOT SAP return-to-duty process are different services. Verify the named evaluator, designation, required report and receiving agency’s acceptance before booking. Clinical treatment or an attendance/fitness letter does not itself clear a legal or safety-sensitive requirement.
An outpatient assessment identifies the substance or behavioral concern, current use, withdrawal and overdose risks, mental health, and the level of care needed. Treatment can include appropriate medication, counseling and practical support. Buprenorphine, methadone and naltrexone have different opioid-treatment pathways; alcohol and tobacco medicines differ, and gambling care is behavioral. Not every concern has an approved medicine, and outpatient care is not suitable for every withdrawal risk. Confirm the actual services and qualified clinicians at the selected program.
An appropriate evaluation or follow-up may be possible by video when the clinician is authorized to treat you where you are physically located. The service must confirm age, eligibility and current prescribing requirements. A video visit does not guarantee a controlled-substance prescription. Some examinations and tests need an in-person visit. Provider-administered injections require the appropriate treatment setting. Ask intake where any ordered specimens must be collected. Tell intake your actual location and requested service.
They are a reason to reassess, but the setting depends on safety, symptoms, support and the full clinical history. A clinician should explain why a more intensive program may help rather than choosing from peer accounts.
Physical withdrawal and urges related to triggers or other conditions are different treatment needs. Discuss timing, medication, mood and circumstances so the plan can be reviewed.
New York OASAS describes medication-assisted treatment as a preferred approach for opioid use disorder, and explains that opioid treatment programs are OASAS-and-federally-certified sites. OASAS also notes that buprenorphine and long-acting naltrexone can be prescribed in other clinical settings when appropriate. See OASAS opioid use disorder guidance.
Long Island
232 W Old Country Rd, Hicksville, NY 11801
A Long Island location for opioid addiction treatment, medication follow-up, and insurance-supported recovery care.
View local MAT details Get directions
Long Island
135 Mineola Blvd, Mineola, NY 11501
A core Long Island location for opioid addiction treatment, insurance review, and reliable ongoing follow-up.
View local MAT details Get directionsPrivate addiction medicine, counseling coordination, insurance review, and local follow-up across NYC and Long Island.
Medical review, counseling coordination, relapse-prevention planning, and VIVITROL or naltrexone discussion when appropriate.
Private assessment, counseling coordination, mental-health review, and specialized referral guidance when needed.
Documentation, testing, MAT, counseling, and probation or court paperwork can be reviewed when instructions are brought in writing.
Outpatient follow-up can help maintain medication, counseling, insurance, and relapse-prevention planning after discharge.
Individual counseling, group therapy planning, substance-use support and medication-treatment coordination.
Private addiction medicine across the Bronx, Brooklyn, Queens, and Manhattan, with MAT, alcohol support, counseling, Medicaid review, court-related documentation review, and telemedicine backup when appropriate.
Bronx addiction medicine access for opioid treatment, alcohol-use concerns, counseling coordination, Medicaid review, court-related needs, and local follow-up.
Brooklyn addiction treatment access for Suboxone and MAT, alcohol-use review, counseling coordination, court-related documentation review, and post-rehab outpatient follow-up.
Queens addiction medicine access in Astoria, Jackson Heights, Jamaica, and Long Island City, with opioid treatment, alcohol support, counseling coordination, Medicaid review, and telemedicine options.
Manhattan addiction medicine through StuyTown, with private medication review, counseling coordination, insurance and Medicaid questions, and virtual follow-up when clinically appropriate.
Long Island addiction treatment access in Hicksville and Mineola, including outpatient addiction care routing, MAT, alcohol-use review, counseling coordination, Medicaid review, and post-rehab follow-up.
Fast evaluation for urgent but non-emergency medication, counseling, testing, safety, and follow-up questions.
Scheduled addiction care for medication, counseling, relapse prevention, testing, insurance, and local follow-up.
Virtual review for selected needs, with local backup when testing, injections, or physical assessment are needed.
Follow-up planning for triggers, cravings, medication gaps, discharge transitions, and higher-risk moments.
Coordinated review for addiction plus anxiety, depression, trauma, insomnia, ADHD, or other concerns.
Testing coordination for treatment monitoring, court instructions, employer requests, MAT, and documentation needs.
Review opioid, stimulant, cannabis, benzodiazepine, prescription medication, kratom, and mixed-substance concerns.
Review cocaine, crack cocaine, methamphetamine, Adderall misuse, sleep, mood, testing, and relapse risk.
Review marijuana or THC use concerns, anxiety, sleep, school or work impact, and family support.
Review opioid pain pills, benzodiazepines, stimulants, sleep medications, withdrawal risk, and medication coordination.
Review naloxone access, family safety planning, opioid risk, fentanyl exposure, and follow-up care.
Review youth, family, school, privacy, consent, mental-health, and referral questions carefully.
Review substance use, safety, testing, documentation, treatment recommendations, insurance, and follow-up.
Review whether an OASAS-certified setting, specific credential, or written requirement may be needed.
Review court, attorney, probation, parole, agency, testing, and documentation requirements.
Review alcohol or drug-related driving requirements and what documentation or treatment may be needed.
Review medication continuity, counseling, cravings, relapse risk, and discharge instructions after detox.
Review Medicaid coverage for MAT visits, testing, counseling, medication, pharmacy benefits, and prior authorization.
Compare local outpatient addiction care access across NYC and Long Island.
Review outpatient addiction medicine when patients are comparing nearby rehab options.
Review scheduled outpatient addiction treatment, medication, counseling, testing, and follow-up.
Review urgent but non-emergency addiction medicine access and same-day limitations.
Review cost factors, insurance, Medicaid, medication, testing, and self-pay options.
Review privacy, self-pay, records release, employer, family, and third-party documentation questions.